Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea
Seung In Seo, Chan Hyuk Park, Seng Chan You, et al.
Gut (2021) Vol. 70, Iss. 11, pp. 2066-2075
Closed Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Management ofHelicobacter pyloriinfection: the Maastricht VI/Florence consensus report
Peter Malfertheiner, Françis Mégraud, Theodore Rokkas, et al.
Gut (2022) Vol. 71, Iss. 9, pp. 1724-1762
Open Access | Times Cited: 775
Proton pump inhibitor use: systematic review of global trends and practices
L.G.T. Shanika, Andrew Reynolds, Sharon Pattison, et al.
European Journal of Clinical Pharmacology (2023) Vol. 79, Iss. 9, pp. 1159-1172
Open Access | Times Cited: 90
Gastritis, Gastric Polyps and Gastric Cancer
Helge L. Waldum, Reidar Fossmark
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6548-6548
Open Access | Times Cited: 98
Proton pump inhibitors and risk of gastric cancer: population-based cohort study
Devin Abrahami, Emily G. McDonald, Mireille E. Schnitzer, et al.
Gut (2021) Vol. 71, Iss. 1, pp. 16-24
Open Access | Times Cited: 93
Helicobacter pylori-Mediated Oxidative Stress and Gastric Diseases: A Review
Lu Han, Xu Shu, Jian Wang
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 46
Association Between Vonoprazan and the Risk of Gastric Cancer After Helicobacter pylori Eradication
Junya Arai, Atsushi Miyawaki, Tomonori Aoki, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 6, pp. 1217-1225.e6
Closed Access | Times Cited: 12
Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases
Won‐Woo Seo, Seung In Seo, Yerim Kim, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 36
Convergent dysbiosis of gastric mucosa and fluid microbiome during stomach carcinogenesis
Cong He, Chao Peng, Xu Shu, et al.
Gastric Cancer (2022) Vol. 25, Iss. 5, pp. 837-849
Open Access | Times Cited: 33
Association of proton pump inhibitors with gastric and colorectal cancer risk: A systematic review and meta-analysis
Huizhu Guo, Ruiqiu Zhang, Pei Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 18
Therapeutic regimens against Helicobacter pylori infection without proton pump inhibitors in patients with corpus atrophic gastritis: a real-life single-centre longitudinal observational study
Emanuele Dilaghi, Lorenzo Mosciatti, Ludovica Dottori, et al.
Therapeutic Advances in Gastroenterology (2025) Vol. 18
Open Access
Proton Pump Inhibitor Use and Risk of Gastric Cancer: Current Evidence from Epidemiological Studies and Critical Appraisal
Tahmina Nasrin Poly, Ming‐Chin Lin, Shabbir Syed-Abdul, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3052-3052
Open Access | Times Cited: 27
The influence of Helicobacter pylori, proton pump inhibitor, and obesity on the gastric microbiome in relation to gastric cancer development
Chengliang Zhou, Tanya M. Bisseling, Rachel S. van der Post, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 23, pp. 186-198
Open Access | Times Cited: 15
Aktualisierte S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Juli 2022 – AWMF-Registernummer: 021–001

Zeitschrift für Gastroenterologie (2023) Vol. 61, Iss. 05, pp. 544-606
Open Access | Times Cited: 13
Real-world performance of indobufen versus aspirin after percutaneous coronary intervention: insights from the ASPIRATION registry
Chunfeng Dai, Muyin Liu, Zheng Yang, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
FZHWT alleviates chronic atrophic gastritis by inhibiting inflammatory pathways and promoting mucosal repair
Xuehui Ma, Yongli Wang, Lingjing Kong, et al.
International Immunopharmacology (2025) Vol. 153, pp. 114473-114473
Closed Access
Gastrin: From Physiology to Gastrointestinal Malignancies
Suzann Duan, Karen Rico, Juanita L. Merchant
Function (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 27
Aspirin, metformin, and statin use on the risk of gastric cancer: A nationwide population‐based cohort study in Korea with systematic review and meta‐analysis
Seung In Seo, Chan Hyuk Park, Tae Jun Kim, et al.
Cancer Medicine (2021) Vol. 11, Iss. 4, pp. 1217-1231
Open Access | Times Cited: 27
Chinese integrated guideline on the management of gastric precancerous conditions and lesions
Ping Wang, Peng Li, Yingxuan Chen, et al.
Chinese Medicine (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 20
Meta‐analysis: Use of proton pump inhibitors and risk of gastric cancer in patients requiring gastric acid suppression
Daniele Piovani, Andreas G. Tsantes, Holger J. Schünemann, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 57, Iss. 6, pp. 653-665
Open Access | Times Cited: 20
Update S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS)
Wolfgang Fischbach, Jan Bornschein, Jörg Hoffmann, et al.
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 02, pp. 261-321
Open Access | Times Cited: 3
Proton Pump Inhibitor for Gastrointestinal Bleeding in Patients with Myocardial Infarction on Dual-Antiplatelet Therapy: A Nationwide Cohort Study
Minyoul Baik, Jimin Jeon, Jinkwon Kim, et al.
Journal of Epidemiology and Global Health (2024) Vol. 14, Iss. 3, pp. 1142-1151
Open Access | Times Cited: 3
Association between proton-pump inhibitors and the risk of gastric cancer: a systematic review and meta-analysis
Tzu‐Rong Peng, Ta‐Wei Wu, Chung‐Hsien Li
International Journal of Clinical Oncology (2022) Vol. 28, Iss. 1, pp. 99-109
Closed Access | Times Cited: 17
Proton pump inhibitor use and the risk of metachronous gastric cancer after H. pylori eradication in patients who underwent endoscopic resection for gastric neoplasms: A population‐based cohort study
Eun Jeong Gong, Hye‐Kyung Jung, Bora Lee, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 7, pp. 668-677
Open Access | Times Cited: 9
Proton pump inhibitors and risk of gastrointestinal cancer: A meta‑analysis of cohort studies
Tien Manh Tran, Seung‐Kwon Myung, Thao Thi Trinh
Oncology Letters (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 8
Long‐term proton pump inhibitor use and risk of osteoporosis and hip fractures: A nationwide population‐based and multicenter cohort study using a common data model
Da‐Hee Park, Seung In Seo, Kyung Joo Lee, et al.
Journal of Gastroenterology and Hepatology (2022) Vol. 37, Iss. 8, pp. 1534-1543
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top